Loading
Latest filing published 26 May 2026 for Helix BioPharma Corp.. Read the official filing
Rohit Babbar appears in our data through filings on Helix BioPharma Corp. shares, published by SEDI. The record holds 4 filings, for trades running from 2 June 2025 to 21 May 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 26 May 2026, the filings show a transaction in Helix BioPharma Corp. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations